Monitoring Infliximab Drug Levels Improves Efficacy Should we start considering therapeutic drug monitoring when prescribing TNFi for treatment of our rheumatologic conditions? Dr. Robert Chao ( @doctorRBC) shares data presented at #ACR21. https://t.co/IJ9by2iguK https://t.co/KBIWTs9iPV

• https://bit.ly/3HdZsAC

Hypertension in AS: Drs. Swetha Ann Alexander ( @swethaann23) interviews Dr. Jean Liew about abstract #0910, presented Sunday at the #ACR21 annual meeting. https://t.co/3oHnLbQAl8 https://t.co/dwxlb4GSzb

• https://bit.ly/3HaZE3l

Pulse Pressure as a Predictor of Carotid Plaque in RA: Dr. Meral El Ramahi ( @MeralElRamahiMD ) discusses abstract #0276 presented at the #ACR21 annual meeting. https://t.co/TkWJ2ehgma https://t.co/6OoTLKlQ1H

• https://bit.ly/3D97zf9

NrAxSpA progression to AxSpA: Dr. Rachel Tate ( @uptoTate) discusses non-radiographic Axial Spondyloarthritis and progression to AS, data from Abstract #0907 presented at the #ACR21 annual meeting. https://t.co/GXJMJ5D9vG https://t.co/JWiQakf30E

• https://bit.ly/3qpsQ0B

More severe COVID-19 outcomes in African American, Hispanic individuals with SLE A study from #ACR21 discussing data from the GRA describes the association between race/ethnicity on COVID-19 outcomes specifically in lupus patients (Abstract #1933). https://t.co/3X7wydVCQR https://t.co/NNbaM0njTX

• https://bit.ly/3kooVNI

To Clot or Not to Clot with Drs. Janet Pope ( @Janetbirdope) and Jeffrey Sparks ( @jeffsparks ) #ACR21 https://t.co/vfOGgTflfl https://t.co/V9cBGAnGnN

• https://bit.ly/3wzkPHk

Risks associated with mortality in VEXAS Dr. Md Yuzaiful Md Yusof ( @Yuz6Yusof) shares findings from abstracts presented at #ACR21. https://t.co/BgYrOaraXC https://t.co/KYLjpi8baP

• https://bit.ly/3c25RAe

Best of PsA Saturday: Dr Rachel Tate ( @uptoTate) discusses "best of" abstracts - #0488, #0453 and #0064 - presented Saturday, at the #ACR21 annual meeting. https://t.co/nMUH6yJTmo https://t.co/x5htYZHq3v

• https://bit.ly/30aZB6w

Telemedicine Enriched Care Model for Autoinflammatory Diseases Dr. Bella Mehta ( @bella_mehta) shares how creative solutions to improve access of our patients with rare diseases may help early diagnoses, decrease complications/ improve outcomes. #ACR21 https://t.co/DM5Qtoj5RD https://t.co/Ruu22maEbn

• https://bit.ly/3ogScuV

11 Ways to Stay Away From RA: Dr. David Liew ( @drdavidliew ) weighs in on abstracts presented at #ACR21. https://t.co/wRTXvXfosA https://t.co/cXDRLpaPwB

• https://bit.ly/3F58m1f

Tired of Doing Nothing About Fatigue: Dr. David Liew ( @drdavidliew ) discusses abstract #0462 presented at the #ACR21 annual meeting. https://t.co/jEUVNNAVsL https://t.co/uwSymr8xuh

• https://bit.ly/3HcFEgC

The Need for Comparative Treatment Trials in Psoriatic Arthritis Dr. Richard Conway ( @RichardPAConway) discusses a small sample of novel agents demonstrating efficacy in PsA presented at #ACR21, we have Abs #453, Abs #488, and Abstract #490. https://t.co/eXBN1XFhRl https://t.co/McxpwTse16

• https://bit.ly/3D4Gw4J

Treating RA: Does Where You Live Matter? Dr. Mrinalini Dey ( @DrMiniDey ) discusses abstract #0494 presented at the #ACR21 annual meeting. https://t.co/xqKSPKelCQ https://t.co/Q6UKuExnwV

• https://bit.ly/2YxcHdU